Clinical Trial Update: Omalizumab Before Onset of Exacerbations [Phase 2]

View source ↗

Summary

This clinical trial update indicates a Phase 2 study evaluating omalizumab to prevent exacerbations in pediatric asthma is currently recruiting, including parti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Atopy
• Viral Upper Respiratory Infection

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: Children's National Research Institute | Conditions: Asthma in Children, Atopy | Phase 2 | Status: RECRUITING